72 related articles for article (PubMed ID: 8836607)
1. Symptomatic myopathies in HIV-1 infected patients untreated with antiretroviral agents--a clinico-pathological study of 30 consecutive patients.
Masanés F; Pedrol E; Grau JM; Coll-Vinent B; Casademont J; Miró O; Mallolas J; Urbano-Márquez A
Clin Neuropathol; 1996; 15(4):221-5. PubMed ID: 8836607
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
[TBL] [Abstract][Full Text] [Related]
3. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
[TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic yield associated with multiple simultaneous skeletal muscle biopsies.
Prayson RA
Am J Clin Pathol; 2006 Dec; 126(6):843-8. PubMed ID: 17074688
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: a clinical and pathological study.
Gherardi R; Baudrimont M; Lionnet F; Salord JM; Duvivier C; Michon C; Wolff M; Marche C
Ann Neurol; 1992 Oct; 32(4):535-42. PubMed ID: 1456737
[TBL] [Abstract][Full Text] [Related]
7. [Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].
Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Antonio Iribarren J; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P;
Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):396-412. PubMed ID: 11153204
[TBL] [Abstract][Full Text] [Related]
8. [Toxic myopathies: clinical, etiologic, and histologic study of 74 cases].
Fernández-Solá J; Pedrol E; Masanés F; Casademont J; Grau JM; Urbano-Márquez A
Med Clin (Barc); 1993 May; 100(19):721-4. PubMed ID: 8315959
[TBL] [Abstract][Full Text] [Related]
9. Low serum carnitine in HIV-infected children on antiretroviral treatment.
Vilaseca MA; Artuch R; Sierra C; Pineda J; López-Vilches MA; Muñoz-Almagro C; Fortuny C
Eur J Clin Nutr; 2003 Oct; 57(10):1317-22. PubMed ID: 14506495
[TBL] [Abstract][Full Text] [Related]
10. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
11. Treatment perceptions and attitudes of older human immunodeficiency virus-infected adults.
Wutoh AK; Brown CM; Dutta AP; Kumoji EK; Clarke-Tasker V; Xue Z
Res Social Adm Pharm; 2005 Mar; 1(1):60-76. PubMed ID: 17138466
[TBL] [Abstract][Full Text] [Related]
12. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
[TBL] [Abstract][Full Text] [Related]
13. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis and other clinical presentation of HIV/AIDS in patients with or without undergoing antiretroviral therapy in Kathmandu.
Dhungana GP; Ghimire P; Sharma S; Rijal BP
Kathmandu Univ Med J (KUMJ); 2007; 5(1):22-6. PubMed ID: 18603981
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of human immunodeficiency virus-infected and -exposed children undergoing surgery--a prospective study.
Karpelowsky JS; Leva E; Kelley B; Numanoglu A; Rode H; Millar AJ
J Pediatr Surg; 2009 Apr; 44(4):681-7. PubMed ID: 19361626
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
17. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
Valle M; Price RW; Nilsson A; Heyes M; Verotta D
Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
[TBL] [Abstract][Full Text] [Related]
18. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F;
Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis.
Domingo P; Vidal F; Domingo JC; Veloso S; Sambeat MA; Torres F; Sirvent JJ; Vendrell J; Matias-Guiu X; Richart C;
Eur J Clin Invest; 2005 Dec; 35(12):771-80. PubMed ID: 16313254
[TBL] [Abstract][Full Text] [Related]
20. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.
Galli M; Ridolfo AL; Adorni F; Cappelletti A; Morelli P; Massetto B; Piazza M; Gianelli E; Vaccarezza M; Gervasoni C; Moroni M
Antivir Ther; 2003 Aug; 8(4):347-54. PubMed ID: 14518704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
